What happens during the study?
The study lasts up to 67 weeks (about 16 months) and has four parts.
Screening
You’ll have tests and health checks to see if you are eligible for the study. Our research staff will discuss informed consent with you as well.
If you are eligible and provide signed consent, you’ll start the study treatment period within five weeks.
Treatment Period 1
You’ll receive the active study drug or placebo and have health checks and tests.
Treatment Period 2
You’ll receive the active study drug (no placebo) and have health checks and tests.
Follow-up Period
After you stop taking the study drug, you’ll have a few more clinic visits. Doctors will check on your health and see how your symptoms respond to cessation of the study drug.
Study Length
67 Weeks
Number of Doses
18
Cost to Participate
No cost
Have questions?
Call our clinical trial line at #(289)-763-8666